Recombinant human interleukin-3 (rH IL-3) in combination with remission induction chemotherapy in patients with relapsed acute myelogenous leukemia (AML): a phase I/II study. [electronic resource]
Producer: 19960226Description: 43-7 p. digitalISSN:- 0887-6924
- Adult
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Combined Modality Therapy
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Female
- Humans
- Interleukin-3 -- administration & dosage
- Leukemia, Myeloid, Acute -- blood
- Leukocyte Count
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Platelet Count
- Recombinant Proteins -- administration & dosage
- Recurrence
- Remission Induction
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.